Prevention

PCR hasn't killed culture. As AMR surveillance expands, selective culture media remain important for viable pathogen isolation, confirmation, characterization, and susceptibility testing. The global market is projected to reach $6.1B by 2035.

Here are the formal rules for the 2026 Winner of the Infection Control Today’s Educator of the Year Award™.

Recent changes from CBIC involving IPUs have opened a much bigger conversation about industry, consultants, commercial bias, continuing education, and professional expertise. In a candid Contagious Conversations discussion, 4 experienced IP professionals ask whether the answer should depend on where an educator works or what that educator actually teaches. It is a conversation the IPC community may need to have sooner rather than later.

Can a UV-C robot make up for a surface that wasn't properly cleaned? Experts say that's the wrong way to think about the technology. UV-C can provide an additional layer of microbial reduction, but factors including shadows, distance, positioning, and exposure time mean it cannot replace thorough manual cleaning and disinfection.

During an expert panel at Exchange26 on whole-room microbial reduction technologies, regulatory and health care leaders discussed the distinction between FDA and EPA oversight, what constitutes a medical device claim, the risks surrounding unauthorized or off-label claims, and why IP and EVS professionals should verify a device's regulatory status rather than relying solely on vendor presentations.

At AHE Exchange26, experts revealed how surprisingly small gaps in linen education can contribute to waste, higher costs, and potential patient safety risks. The solution begins with something simple: helping everyone who touches health care linen understand why their role matters.

The childhood vaccine schedule is changing, but what happens when preventing disease becomes more complicated for families? Public health and infection prevention experts are raising concerns about access, missed vaccination opportunities, vaccine confidence, and what the changes could ultimately mean inside health care facilities.

The Bug of the Month helps educate readers about existing and emerging pathogens that are clinically important in today's health care facilities. This month’s Bug of the Month isn’t quite like anything we’ve featured before. Can you solve the clues before the final reveal?

In this podcast with ICT, Danielle Updegraff, MBA, BSN, RN, discusses real-time location systems, which can give infection prevention teams greater visibility into hand hygiene, workflow, and infectious disease exposures, but sustainable improvement still depends on staff engagement, leadership, education, and culture.

In this complete interview, ICT speaks with Endale Tilahun, MD, MPH, about a Malawi community program that reduced missed HIV testing and achieved 0.2% positivity among exposed infants through household follow-up, individualized case management, and coordinated health and social support.

A new $17 million international clinical trial will evaluate personalized phage therapy for recurrent antibiotic-resistant urinary tract infections, bringing together researchers from 13 countries.

Merck has announced that the FDA accepted its supplemental application to expand ENFLONSIA's indication to include children younger than 2 years who remain at increased risk for severe RSV disease during their second RSV season.

Roche has introduced 2 new research-use PCR assays for Cyclospora cayetanensis, expanding laboratory testing options as public health officials continue to respond to one of the largest Cyclospora outbreaks in US history.

Claryx has emerged from stealth with funding and a genomic surveillance platform designed to help hospitals identify hidden transmission chains, trace infection sources, and intervene before outbreaks grow.

Sina Bavari, PhD, discusses promising preclinical findings for the investigational TNX-801 vaccine, emerging mpox variants, durable immunity, and why infection preventionists should continue preparing for future outbreaks.

After experiencing severe professional burnout, an infection preventionist found renewed purpose by mentoring others, seeking mentorship herself, and rebuilding connection, confidence, and commitment to her career.

Federal officials say new gain-of-function restrictions will improve biosecurity, but infectious disease experts warn limiting carefully regulated research could weaken preparedness for future outbreaks and emerging public health threats.

Evidence-based guidance outlines practical strategies for preventing infectious disease outbreaks in K–12 schools through hand hygiene, environmental cleaning, ventilation, illness monitoring, vaccination, and food safety.

New US Ebola travel restrictions require many travelers leaving the DRC to spend 21 days outside the country before returning home, creating logistical, financial, and operational challenges for health care responders.

Phase 3 ISLEND trials presented at AIDS 2026 found an investigational once-weekly oral HIV regimen maintained viral suppression comparable to daily therapy while improving treatment satisfaction and flexibility.

Environmental testing found bacterial contamination on many lead garments and described what lead garment cleaning technicians routinely encounter during servicing.

Hospitals still rely on manual temperature checks for vaccines, meds, blood, and lab samples, risking costs and safety. Automation improves adherence, reduces waste, boosts efficiency, and enables real-time visibility for smarter operations.

Foodborne outbreaks like Cyclospora are often blamed on contaminated produce, but delayed data sharing may be the larger problem. This article examines how modern digital traceability, standardized data systems, and faster outbreak investigations could reduce illnesses and improve food safety across the supply chain.

New research presented at AIDS 2026 indicates that 2-drug HIV regimens and long-acting injectable therapies are effective treatment options that also enhance personalized care. Investigators highlight that shared decision-making, adherence, quality of life, and minimizing long-term medication exposure are becoming more vital alongside maintaining viral suppression.

Food safety experts explain how epidemiology, traceback investigations, surveillance, and food safety practices work together to identify contamination sources during Cyclospora outbreaks while highlighting ongoing challenges in protecting the food supply.